Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aprea Therapeutics Inc (NQ: APRE )

4.685 +0.135 (+2.97%)
Streaming Delayed Price Updated: 9:35 AM EDT, Mar 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Aprea Therapeutics Inc

Aprea Therapeutics Announces Presentation of Preclinical Data on Pipeline Programs at the AACR 2023 Annual Meeting
From Aprea Therapeutics
Via Globe NewsWire
Aprea Therapeutics to Present at Oppenheimer’s 33rd Annual Healthcare Conference
From Aprea Therapeutics
Via Globe NewsWire
Aprea Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Aprea Therapeutics
Via Globe NewsWire
Aprea Therapeutics Announces Closing of $5.5 Million Underwritten Public Offering of Common Stock
From Aprea Therapeutics
Via Globe NewsWire
Aprea Therapeutics Announces Pricing of $5.5 Million Underwritten Public Offering of Common Stock
From Aprea Therapeutics
Via Globe NewsWire
Aprea Therapeutics Announces Proposed Public Offering of Common Stock
From Aprea Therapeutics
Via Globe NewsWire
Aprea Therapeutics Announces Phase II SBIR Award from the National Cancer Institute (NCI)
From Aprea Therapeutics
Via Globe NewsWire
Aprea Therapeutics Announces One-for-Twenty Reverse Stock Split
From Aprea Therapeutics
Via Globe NewsWire
Aprea Therapeutics Appoints John Hamill as Chief Financial Officer
From Aprea Therapeutics
Via Globe NewsWire
Aprea Therapeutics to Participate in 6th Annual DNA Damage and Response (DDR) Inhibitors Summit
From Aprea Therapeutics
Via Globe NewsWire
Aprea Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of Oral ATR Inhibitor ATRN-119 for the Treatment of Advanced Solid Tumors
From Aprea Therapeutics
Via Globe NewsWire
Aprea Therapeutics Reports Third Quarter 2022 Financial Results and Provides Update on Business Operations
From Aprea Therapeutics
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.